Valproate in pregnancy: authors' reply

Affiliations

¹ Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Switzerland / Hospital Pharmacy, University Hospital Basel, Switzerland.
² SWITZERLAND.

Free article

Comment

Julia Spoendlin et al. Swiss Med Wkly. 2021.

Free article

. 2021 Feb 19:151:w20481.

doi: 10.4414/smw.2021.20481. eCollection 2021 Feb 15.

¹ Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Switzerland / Hospital Pharmacy, University Hospital Basel, Switzerland.
² SWITZERLAND.

No abstract available

Comment on

Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims data.
Spoendlin J, Blozik E, Graber S, Rauch M, Marxer C, Rüegg S, Meier C, Winterfeld U, Panchaud A. Spoendlin J, et al. Swiss Med Wkly. 2021 Jan 10;151:w20386. doi: 10.4414/smw.2021.20386. eCollection 2021 Jan 1. Swiss Med Wkly. 2021. PMID: 33423241
Valproate in pregnancy: comment from the SAPP.
von Mandach U, Hösli I, Swiss Academy For Perinatal Pharmacology Sapp. von Mandach U, et al. Swiss Med Wkly. 2021 Feb 19;151:w20476. doi: 10.4414/smw.2021.20476. eCollection 2021 Feb 15. Swiss Med Wkly. 2021. PMID: 33641107 No abstract available.